Skip to main content
Polaris AI Pharma Corp. logo

Polaris AI Pharma Corp. — Investor Relations & Filings

Ticker · 041910 ISIN · KR7041910001 KO Manufacturing
Filings indexed 164 across all filing types
Latest filing 2024-04-11 Director's Dealing
Country KR South Korea
Listing KO 041910

About Polaris AI Pharma Corp.

https://polarisaipharma.com/

Polaris AI Pharma Corp., formerly known as ESTECHPHARMA CO., LTD, is a company engaged in the development, manufacture, and supply of active pharmaceutical ingredients (APIs) and fine chemicals. The company specializes in producing raw materials for generic drugs across various therapeutic categories. Its product portfolio includes APIs for treatments such as anti-thrombosis, anti-ulcer, asthma, and alcohol dependence.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서), which is a standard regulatory filing in South Korea (DART system) used to disclose insider trading or changes in shareholdings by company directors and major shareholders. This corresponds to the 'Director's Dealing' category.
2024-04-11 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically regarding a change in the largest shareholder and management control of the company 'Estechpharma'. This type of filing is used to notify the market of significant changes in shareholding thresholds and control, which falls under the 'Major Shareholding Notification' category.
2024-03-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in Korea. This type of filing is specifically used to report insider transactions, changes in share ownership by directors, or major shareholders. According to the provided definitions, this corresponds to 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2024-03-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과) for the company '에스텍파마'. It details the outcomes of agenda items such as financial statement approval, dividend declarations, election of directors and auditors, and amendments to business purposes. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2024-03-28 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the CEO (Representative Director) of the company 'S-Tech Pharma'. It details the previous and new CEO, the reason for the change, the date of the board resolution, and the professional background of the new CEO. This falls directly under the category of Board/Management Information (MANG).
2024-03-28 Korean
상호변경안내
AGM Information Classification · 100% confidence The document is a formal announcement regarding a change of company name (from ESTECHPHARMA to Polaris AI Pharma). It provides details on the change, the reason, and the date of the shareholder meeting where this was approved. Since this is a corporate announcement that does not fit into specific financial reporting categories like 10-K or IR, and it is not a report publication announcement, it falls under the general regulatory filing category.
2024-03-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.